GABRP
MOLECULAR TARGETgamma-aminobutyric acid type A receptor subunit pi
GABRP (gamma-aminobutyric acid type A receptor subunit pi) is targeted by 12 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting GABRP
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | gamma-Aminobutyric Acid | 3.22 | 24 |
| 2 | Pregnanolone | 2.20 | 8 |
| 3 | Apigenin 5,7,4'-trihydroxy-flavone, | 1.10 | 2 |
| 4 | chrysin | 1.10 | 2 |
| 5 | Androsterone | 1.10 | 2 |
| 6 | Bicuculline | 1.10 | 2 |
| 7 | Ciprofloxacin | 0.69 | 1 |
| 8 | Etiocholanolone | 0.69 | 1 |
| 9 | Etomidate Imidazole derivative anesthetic and hypnotic with little effect on blood gases, ventilation, or | 0.69 | 1 |
| 10 | Ondansetron | 0.69 | 1 |
| 11 | Picrotoxin | 0.69 | 1 |
| 12 | Triiodothyronine | 0.69 | 1 |
About GABRP as a Drug Target
GABRP (gamma-aminobutyric acid type A receptor subunit pi) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 12 compounds with documented GABRP interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
GABRP inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.